New Harbor Capital Portfolio Company Access Infusion Care Completes Acquisition of Big Sky I.V. Care
Acquisition expands AIC’s presence in a new underserved market
New Harbor Capital announced today that its portfolio company Access Infusion Care (“Access”, “AIC”) has completed the acquisition of Superior Specialty Pharmacy, LLC and Big Sky Pharmacy Management Inc. dba Big Sky I.V. Care (“Big Sky”, “the Company”), a provider of home and specialty infusion services in Kalispell, Montana. The Company offers a wide range of infusion therapies, including specialty medications, antibiotics, and total parenteral nutrition for chronically ill patients in patients’ homes and infusion suites. This acquisition marks AIC’s first add-on in partnership with New Harbor and is a key part of its broader strategy to partner with high-quality infusion providers in underserved areas with diversified therapy offerings and delivery settings, and outsized growth potential.
Founded in 2005 in Kalispell, Montana by Julie Lyon, BSN, and Dave Grady, BA, Big Sky I.V. Care provides high-quality infusion services to the region. The Company operates a 503A compounding pharmacy and a state-of-the-art ambulatory infusion center facility with a dedicated team of over fifteen professionals, including pharmacists, technicians, and nurses, providing high-quality infusion therapies to chronically ill patients. Big Sky is ACHC accredited for home infusion therapy and features USP <797> and USP <800> compliant clean rooms for sterile compounding. The Company is recognized for its commitment to excellent patient care and innovative infusion solutions.
“We are excited to add another high-quality infusion business to the Access family,” said Bo Mlnarik, Principal at New Harbor Capital. “The combined resources, culture and experience of the teams, as well as the added scale, diversification and growth avenues make this a great fit for our infusion strategy.”
“We are thrilled to announce our new partnership with the Big Sky I.V. Care team,” said Bruce Kutinsky, CEO of Access Infusion Care. “Julie and Dave have built an impressive and innovative business with a diverse array of service offerings and world-class facilities. This acquisition is a significant step forward in fulfilling our vision of bridging the access gap in healthcare. By improving access to specialized infusion therapies in underserved markets, we are making a tangible difference in the lives of patients who need these services the most. We are excited about the future and the potential to transform the infusion care landscape through this strategic partnership with Big Sky I.V. Care.”
“We look forward to joining the Access Infusion Care team,” said Dave Grady, Founder of Big Sky I.V. Care. “The opportunity to combine their extensive experience with our local expertise and an aligned vision of excellence was compelling. With the support of New Harbor Capital, we will significantly expand our capacity to deliver the best possible infusion therapy services to our patients in the region. By reaching more people, we aim to improve the health and longevity of the communities we serve, as we have for many years.”
McDermott, Will & Emery LLP and RSM US LLP provided counsel and advice to Access Infusion Care. Triangle Healthcare Advisors served as advisors to Big Sky I.V. Care on the transaction.
About Access Infusion Care
Access Infusion Care is a diversified specialty and infusion pharmacy services provider focused on providing high-quality infusion therapies for patients in the home and suite settings. The Company was formed in January 2024 through the acquisition of AIC North and JLS Infusion Nurse Staffing Services and seeks to acquire high-quality infusion providers in underserved geographies with diversified therapy offerings and delivery settings, and outsized growth potential.